Cite Filings / PLX / 0001104659-22-053664

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Protalix BioTherapeutics, Inc. Filed 2022-04-29 Acc 0001104659-22-053664

Documents 1

DEF 14A Proxy Statement , tm2213754-1_def14a.htm

Around this filing

2023-05-18 DEF 14A Proxy Statement
2022-05-02 8-K Material agreement
2022-05-02 424B5 Prospectus
2022-04-29 EFFECT Notice of Effectiveness
2022-04-29 DEF 14A Proxy Statement
2022-04-27 CORRESP Correspondence Between Filers and SEC Staff
2021-09-30 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading tm2213754-1_def14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…